The combination of LILRB4-targeting NK cell engagers and cGAS–STING agonists enhances the anti–multiple myeloma immune activity of NK cells - Meng Li; Yuwei Zhao; Lizhou Zhao; Xue Chen; Jianxun Kang; Aiping Tong; Chen Yang; Ping Wang; Minjun Yang; Kejiang Wang; Jialiang Gao; Ying Li; et al. (PLoS ONE, 2025)